Skip to main content
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.280
+0.065 (2.02%)
Apr 29, 2026, 9:24 AM CET

Elicera Therapeutics AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Other Revenue
10.6410.867.1311.231.280
Upgrade
Revenue
10.6410.867.1311.231.280
Upgrade
Revenue Growth (YoY)
146.66%52.28%-36.52%777.23%217987.39%-
Upgrade
Gross Profit
10.6410.867.1311.231.280
Upgrade
Selling, General & Admin
25.6328.82428.3120.6313.11
Upgrade
Operating Expenses
25.6328.824.0128.3320.6413.12
Upgrade
Operating Income
-14.99-17.94-16.88-17.1-19.36-13.12
Upgrade
Interest Expense
-0.01-0.01-0.05-0.08-0.13-0
Upgrade
Interest & Investment Income
0.550.550.830.770.05-
Upgrade
Other Non Operating Income (Expenses)
--0--0
Upgrade
EBT Excluding Unusual Items
-14.45-17.41-16.11-16.4-19.44-13.12
Upgrade
Pretax Income
-14.45-17.41-16.11-16.4-19.44-13.12
Upgrade
Net Income
-14.45-17.41-16.11-16.4-19.44-13.12
Upgrade
Net Income to Common
-14.45-17.41-16.11-16.4-19.44-13.12
Upgrade
Shares Outstanding (Basic)
494632202016
Upgrade
Shares Outstanding (Diluted)
494632202016
Upgrade
Shares Change (YoY)
36.74%44.30%59.89%-0.40%23.97%32.98%
Upgrade
EPS (Basic)
-0.30-0.38-0.51-0.83-0.98-0.82
Upgrade
EPS (Diluted)
-0.30-0.38-0.51-0.83-0.98-0.82
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-140.95%-165.31%-236.86%-152.24%-1512.51%-2234986.20%
Upgrade
Profit Margin
-135.89%-160.35%-226.01%-146.02%-1518.44%-2235169.17%
Upgrade
EBITDA
--17.93-16.87-17.08-19.35-13.11
Upgrade
EBITDA Margin
--165.20%-236.70%-152.13%--
Upgrade
D&A For EBITDA
-0.010.010.010.010.01
Upgrade
EBIT
-14.99-17.94-16.88-17.1-19.36-13.12
Upgrade
EBIT Margin
-140.95%-165.31%-236.86%-152.24%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.